Navigation Links
Faruqi & Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc.
Date:2/9/2012

NEW YORK, Feb. 9, 2012 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at BioSante Pharmaceuticals, Inc. ("BioSante" or the "Company") (Nasdaq: BPAX).   

(Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO )

The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that:  (1) BioSante's LibiGel product was ineffective and failed to deliver desired results; (2) the Company's LibiGel clinical demonstrations were faring poorly; and (3) LibiGel lacked any supposed multi-billion dollar market potential, similar to drugs Viagra, Levitra, and Cialis.

On February 12, 2010, the Company issued positive statements to investors about LibiGel's commercial viability, effectiveness, and market potential that caused shares of BioSante to trade at artificially high prices.  Specifically, officials at BioSante boasted that clinical data demonstrated that LibiGel had a "statistically significant" effect on female patients treated with the product, and that LibiGel was "the most clinically advanced pharmaceutical product in the U.S."  Additionally, BioSante and its Chief Executive Officer routinely analogized LibiGel's market potential to the $2 billion dollar market for male erectile drugs, often comparing LibiGel to products like "Viagra, Levitra, and Cialis."

On December 14, 2011, BioSante issued a press release disclosing for the first time that LibiGel failed to yield positive results in large-scale efficacy tests designed by the Company.  According to study results, women treated with LibiGel did not experience statistically significant increases in either total satisfying sexual encounters or sexual desire.  On this news, shares of BioSante declined by over 75% of their value.  After t
'/>"/>

SOURCE Faruqi & Faruqi, LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Faruqi & Faruqi, LLP Announces Investigation of GenVec, Inc.
2. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays
3. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
4. Tata Interactive Systems Partners With Bersin & Associates for Exclusive Executive Learning Forum - TLF 2009
5. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
6. Robbins & Myers Announces Regular Quarterly Cash Dividend
7. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
8. Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year
9. Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
10. Robbins & Myers Announces Fourth Quarter and Full Year 2009 Results
11. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... CHASE, Md. , June 2, 2015 ... release of its National Practice Guideline for the Use ... Use ( Practice Guideline ).  The Practice Guideline ... addiction related to opioid use. It addresses knowledge gaps ... in recovery, while guiding evidence-based coverage standards by payers. ...
(Date:6/2/2015)... N.Y. , June 2, 2015   ... and solutions, today announced a series of corporate ... about strategies to reduce the threat of antimicrobial-resistant ... the US Centers for Disease Control and Prevention ... National Strategy to Combat Antibiotic-Resistant Bacteria. ...
(Date:6/2/2015)... , June 02, 2015 Research and Markets( ... Mammography Market - Growth, Trends And Forecasts (2014 - 2019)" ... market is dominated by the Germany . ... . Developing nations such as Poland ... for mammography equipment can be segmented on the basis of ...
Breaking Medicine Technology:American Society of Addiction Medicine Releases National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use 2American Society of Addiction Medicine Releases National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use 3PDI Partners with White House and Centers for Disease Control and Prevention (CDC) to Combat Antimicrobial Resistance 2Europe Mammography Market Report 2014-2019 - Growth, Trends And Forecasts 2
... 29 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems,Ltd. (Nasdaq: DHRM ), an emerging leader ... China ,today announced members of its Executive Management will ring the NASDAQ Stock,Market ... , , ... , , ...
... HARBIN, China , June 29 /PRNewswire-Asia-FirstCall/ ... the "Company"), a,developer, manufacturer and distributor of botanical ... the Company plans to launch a new biopharmaceutical ... 2010 . Renhuang estimates that the new product,will ...
Cached Medicine Technology:Dehaier Medical Systems Chief Executive Officer To Ring NASDAQ Stock Market Closing Bell 2Dehaier Medical Systems Chief Executive Officer To Ring NASDAQ Stock Market Closing Bell 3Renhuang to Launch New Bio-pharmaceutical Product - Ginseng and Deer Antler Extract 2Renhuang to Launch New Bio-pharmaceutical Product - Ginseng and Deer Antler Extract 3Renhuang to Launch New Bio-pharmaceutical Product - Ginseng and Deer Antler Extract 4
(Date:6/2/2015)... June 02, 2015 UCLA Health and ... intent to partner and expand urgent care services in ... approval by the University of California Board of Regents ... will allow UCLA Health to purchase a minority share ... Hills, Calabasas, Newbury Park and Northridge and creates opportunity ...
(Date:6/2/2015)... TMG Health, the leading national provider ... the Medicare Advantage, Medicare Part D, and Managed Medicaid ... at AHIP’s Institute 2015, the annual meeting of the ... will be held June 3-5 in Nashville, Tenn. , ... for attendees to schedule private discussions with senior members ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 On October ... congressional efforts for another delay. , On Monday, ... Health Subcommittee for the House Ways and Means Committee, ... to Centers for Medicare and Medicaid Services, urging the ... as CMS rolls out ICD-10. ICD-10 is the newest ...
(Date:6/2/2015)... Angeles, California (PRWEB) June 02, 2015 ... sealers and sorbent systems, has announced the availability ... accidental ingestion of poisons by children, especially curious ... ASTM D3475 standards and tested to CFR 1700.20 ... Director Kevin Cullen. , Looks Like Candy, “With ...
(Date:6/2/2015)... June 02, 2015 Olive ... opening of Surrey’s first fertility clinic. Surrey ... a diverse, young community, with one of ... , Until now patients from Surrey ... to come into Vancouver or Burnaby for ...
Breaking Medicine News(10 mins):Health News:UCLA Health Partners With Exer - More Than Urgent Care 2Health News:TMG Health to Sponsor and Exhibit at AHIP’s Institute 2015 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 3Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 4Health News:IMPAK Introduces Child Resistant Zip Pouches & Bags 2Health News:Olive Fertility Centre Opens First Fertility Clinic in Surrey BC 2
... women's with damaged or missing wombs by saying in ... to have children normally. // ,After ... transplantation would be possible in humans too without any ... syndrome (a rare congenital condition affecting womb) can also ...
... health boards' (DHB) long running disagreement over the funding of ... are forced to travel to Christchurch for specialist treatment. ... the treatment of cervical and other gynecological cancers and was ... has still not been ordered because the DHB wants other ...
... plague is a respiratory disease and is endemic to the ... to occur//. If the disease is not diagnosed at an ... If diagnosed at an early stage then the patient can ... disease has already killed 22 people and this highly contagious ...
... Institute for Public Health had reported on Thursday that a ... of mad cow disease, last year a woman died from ... Environment (RIVM) did not however disclose any further details about ... issue a statement that eating contaminated meat products would have ...
... in Germany have announced progress in their collaborative ... the treatment of hemophilia. ,Extensive in ... synthetic lead molecules with promising pharmacological properties. ... to make important progress in our collaboration with ...
... against sunscreen manufacturers in California as they had exaggerated the ... hand still recommend the liberal use of sunscreen. But some ... the label on the products gives a clear picture to ... but do cause aging of the skin and potentially cancer. ...
Cached Medicine News:Health News:Advance in Program for Development of Non-Intravenous Therapy for Hemophilia 2Health News:Advance in Program for Development of Non-Intravenous Therapy for Hemophilia 3
The AVL Omni modular system is a complete blood gas solution designed for high-volume critical care use, with customized test combinations, minimum intervention and flexibility....
... in one. With speeds up to ... 100SE Ultracentrifuge offers unsurpassed performance. All ... performance, powerful functionality, and revolutionary ease ... smallest, quietest, floor model ultra on ...
... highest g-force ever. But optimal productivity in ... MAX combines maximum force, capacity, and ease ... worlds apart from any other system. With ... efficiency, Optima takes productivity to the MAX. ...
... Efficiency, versatility, and environmental safety ... Optima LE-80 K Ultracentrifuge from ... innovative Optima centrifugation technology, the ... cost effectively provide advanced capability ...
Medicine Products: